In a panel discussion during MedCity INVEST Thursday, investors discussed how the Covid-19 pandemic and social distancing requirements have impacted the way they interact with companies.
Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what's changed and how they're working in the midst of the crisis.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Gain insights from the perspectives of healthcare investors from Maverick Ventures, Cultivation Capital, Advocate Aurora Health and Flare Capital on investment trends in 2020 at the online conference July 20-24. Register now and save.
How have traditional venture capital and strategic investors adjusted to the reality of Covid-19? Learn how investment goals and strategies are being reshaped in this panel discussion. Register now for the Earlybird rate.
Bain Capital Ventures, Health X Ventures and Cultivation Capital led the funding round for the Madison, Wisconsin-based startup.
LiveOak Venture Partners, Cultivation Capital and HealthX Ventures led the round. The business has raised $4 million to date.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.